Evidence map›Paper›PMID 33481895›Full record

ArticlePloS one2021

Treatment burden experienced by patients with lung cancer.

Nicole El-Turk, Michael S H Chou, Natasha C H Ting, Afaf Girgis, Shalini K Vinod, Victoria Bray, Claudia C Dobler

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Reporting time toxicity in prospective cancer clinical trials: A scoping review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Nicole El-TurkDepartment of Respiratory and Sleep Medicine, Liverpool Hospital, Sydney, NSW, Australia.ORCID 0000-0003-1112-9670
Michael S H ChouDepartment of Respiratory and Sleep Medicine, Liverpool Hospital, Sydney, NSW, Australia.
Natasha C H TingDepartment of Respiratory and Sleep Medicine, Liverpool Hospital, Sydney, NSW, Australia.
Afaf GirgisSouth Western Sydney Clinical School, University of New South Wales, Sydney, NSW, Australia.
Shalini K VinodSouth Western Sydney Clinical School, University of New South Wales, Sydney, NSW, Australia.ORCID 0000-0001-8075-6219
Victoria BrayCentre for Oncology Education and Research Translation (CONCERT), Ingham Institute for Applied Medical Research, Sydney, NSW, Australia.
Claudia C DoblerDepartment of Respiratory and Sleep Medicine, Liverpool Hospital, Sydney, NSW, Australia.ORCID 0000-0002-5460-0189
Liverpool Hospital · AUBond University · AUUNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPatients' burden from lung cancer treatment is not well researched, but this understanding can facilitate a patient-centred treatment approach. Current models of treatment burden suggest it is influenced by a patient's perception of their disease and treatment and their capacity to do the work required to treat their disease.

methodsSixteen patients and 1 carer who were undergoing or had completed conventional or stereotactic ablative radiotherapy, chemotherapy or immunotherapy for lung cancer in the last 6 months participated in a semi-structured interview. A treatment burden framework was used with three main themes: a) treatment work, b) consequences of treatment and c) psychosocial factors affecting treatment burden.

resultsThe majority of patients did not feel unduly burdened by treatment tasks, despite having a large treatment-associated workload. Many saw treatment as a priority, causing them to restructure their life to accommodate for it. Patients wished that they would have been better informed about the lifestyle changes that they would have to make before treatment for lung cancer commenced and that the health service would provide services to assist them with this task. DISCUSSION: While there was a large burden associated with lung cancer treatment, patients felt motivated and equipped to manage the workload because the disease was considered severe and life-threatening, and the treatment was seen as beneficial. Before initiating treatment for lung cancer, patients should be informed about lifestyle changes they likely have to make and should be offered assistance.

Indexed as

AgedAged, 80 and overEmotionsFatigueFemaleHumansInterviews as TopicLung NeoplasmsMaleMiddle Aged

Identifiers

PMID33481895
PMCPMC7822249
OpenAlexW3125831186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.